Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Metabolites (2023) 13(1):129
Saxenda (liraglutide 3 mg for weight loss) is being phased out by Novo Nordisk globally as the company reallocates manufacturing capacity toward newer GLP-1 medications
Clinical trials demonstrate average weight reductions of 15-20% body weight when coupled with lifestyle modifications, positioning it as a front-runner in weight loss treatments
The $399 price for the lowest dose is still almost $5,000 a year an insurmountable cost for many racial and ethnic minorities, she said
US$ 21.99
US$ 25.92
US$ 24.47
US$ 21.00
US$ 25.50
